Cargando…
An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial
OBJECTIVES: Primary objective: To determine the efficacy of a candidate antiviral on time to virological cure compared to standard of care within 14 days of randomisation Secondary objectives: • To determine the safety of the antiviral • To determine the clinical benefit of the antiviral over placeb...
Autores principales: | McMahon, James H., Lau, Jillian S. Y., Roney, Janine, Rogers, Benjamin A., Trubiano, Jason, Sasadeusz, Joseph, Molton, James S., Gardiner, Bradley, Lee, Sue J., Hoy, Jennifer F., Cheng, Allen, Peleg, Anton Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552590/ https://www.ncbi.nlm.nih.gov/pubmed/33050947 http://dx.doi.org/10.1186/s13063-020-04766-5 |
Ejemplares similares
-
Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial
por: McMahon, James H., et al.
Publicado: (2022) -
Effect of high dose vitamin D(3) on the HIV-1 reservoir: A pilot randomised controlled trial
por: Pitman, Matthew C., et al.
Publicado: (2023) -
The BREATHE study: Breathing REtraining for Asthma — Trial of Home Exercises. A protocol summary of a randomised controlled trial
por: Bruton, Anne, et al.
Publicado: (2013) -
Increasing recruitment to randomised trials: a review of randomised controlled trials
por: Watson, Judith M, et al.
Publicado: (2006) -
The Hawthorne Effect: a randomised, controlled trial
por: McCarney, Rob, et al.
Publicado: (2007)